BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Elkady A, Aboulfotuh S, Ali EM, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Iijima S, Tanaka Y. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt. World J Gastroenterol 2013; 19(37): 6214-6220 [PMID: 24115819 DOI: 10.3748/wjg.v19.i37.6214]
URL: https://www.wjgnet.com/1007-9327/full/v19/i37/6214.htm
Number Citing Articles
1
Ghada F. Helaly, Ebtisam F. El Ghazzawi, Sherine M. Shawky, Farag M. Farag. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, EgyptJournal of Infection and Public Health 2015; 8(6): 562 doi: 10.1016/j.jiph.2015.04.019
2
C. Sagnelli, M. Macera, M. Pisaturo, R. Zampino, M. Coppola, E. Sagnelli. Occult HBV infection in the oncohematological settingInfection 2016; 44(5): 575 doi: 10.1007/s15010-016-0891-1
3
Jason T. Blackard, Kenneth E. Sherman. Hepatitis B virus (HBV) reactivation—The potential role of direct‐acting agents for hepatitis C virus (HCV)Reviews in Medical Virology 2018; 28(4) doi: 10.1002/rmv.1984
4
Mona Fouad, Omar Abdel-Rahman. Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literatureArab Journal of Gastroenterology 2015; 16(2): 40 doi: 10.1016/j.ajg.2015.03.003
5
Mohammed El-Mowafy, Mohamed Elegezy, Mohamed El-Mesery, Abdelaziz Elgaml. Novel method for cloning of hepatitis B virus DNA using the In-Fusion enzymeGene Reports 2023; 31: 101765 doi: 10.1016/j.genrep.2023.101765
6
Ashraf Elbahrawy, Alshimaa Alaboudy, Walid El Moghazy, Ahmed Elwassief, Ahmed Alashker, Abdallah Mahmoud Abdallah. Occult hepatitis B virus infection in EgyptWorld Journal of Hepatology 2015; 7(12): 1671-1678 doi: 10.4254/wjh.v7.i12.1671
7
Abeer Elkady, Sayuki Iijima, Sahar Aboulfotuh, Elsayed Mostafa Ali, Douaa Sayed, Nashwa M Abdel-Aziz, Amany M Ali, Shuko Murakami, Masanori Isogawa, Yasuhito Tanaka. Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South EgyptWorld Journal of Hepatology 2017; 9(9): 477-486 doi: 10.4254/wjh.v9.i9.477
8
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic. Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon ImmunosuppressionViruses 2019; 11(9): 778 doi: 10.3390/v11090778
9
Multiple drugsReactions Weekly 2021; 1853(1): 323 doi: 10.1007/s40278-021-95189-0
10
Mohammed El-Mowafy, Mohamed Elegezy, Mohamed El-Mesery, Abdelaziz Elgaml. Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infectionVirus Genes 2024; 60(2): 235 doi: 10.1007/s11262-024-02055-w
11
Evangelista Sagnelli, Mariantonietta Pisaturo, Salvatore Martini, Pietro Filippini, Caterina Sagnelli, Nicola Coppola. Clinical impact of occult hepatitis B virus infection in immunosuppressed patientsWorld Journal of Hepatology 2014; 6(6): 384-393 doi: 10.4254/wjh.v6.i6.384
12
Rhiannon M. Bath, Brandelyn E. Doering, Michael D. Nailor, Kellie J. Goodlet. Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic ReviewAnnals of Pharmacotherapy 2019; 53(3): 294 doi: 10.1177/1060028018800501
13
Tamer A. Elbedewy, Hossam Eldin A. Elashtokhy, Enaam S. Rabee, Gamal E. Kheder. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screeningJournal of the Egyptian National Cancer Institute 2015; 27(1): 11 doi: 10.1016/j.jnci.2015.01.004
14
Elio Castagnola, Eliana Ruberto, Alfredo Guarino. Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000World Journal of Gastroenterology 2016; 22(25): 5853-5866 doi: 10.3748/wjg.v22.i25.5853
15
Nivin Abdel-azim, Lamiaa Fadel Alkilany, Zeinab Korany Hassan, Noha Gaber. Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patientsInfection 2023; 51(1): 203 doi: 10.1007/s15010-022-01878-9
16
Kazuhiko Hayashi, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Yoshihiko Tachi, Tetsuya Ishikawa, Yoshiaki Katano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada, Hidemi Goto, Yoshiki Hirooka. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapyJournal of Gastroenterology 2016; 51(11): 1081 doi: 10.1007/s00535-016-1187-z
17
Mohammed El‐Mowafy, Abdelaziz Elgaml, Mohamed El‐Mesery, Mohamed Elegezy. Molecular analysis of Hepatitis B virus sub‐genotypes and incidence of preS1/preS2 region mutations in HBV‐infected Egyptian patients from MansouraJournal of Medical Virology 2017; 89(9): 1559 doi: 10.1002/jmv.24828
18
Pengfei Deng, Tian Yang, Hua Zhang, Fen Zhou, Caoyi Xue, Yi Fei, Yijin Gao. Prospective clinical trial of hepatitis B vaccination for children with hematological malignancies: a study on the safety and immunogenicity efficacyHuman Vaccines & Immunotherapeutics 2021; 17(11): 4578 doi: 10.1080/21645515.2021.1953303